In an important update, pharmaceutical giant Mylan has voluntarily recalled 13 lots of EpiPen and EpiPen Jr. devices across the nation due to a possible defect. This proactive measure is crucial, considering the life-saving role these devices play for individuals facing severe allergic reactions.
The announcement, made on Mylan’s official website, indicates that the likelihood of encountering the defect is minimal. However, Mylan is taking this action out of “an abundance of caution” to prevent any faulty pens from being used. The recall follows reports from abroad of devices that failed to activate due to a defect in a component provided by a supplier. Notably, both incidents were linked to a single lot that had already been recalled, prompting Mylan to expand the recall to include additional lots for safety.
According to the company, the defect in question could impede activation of the EpiPen, necessitating extra force or leading to total failure, which would delay critical treatment during an allergic emergency. The recall encompasses lots distributed between December 17, 2015, and July 1, 2016. To check if your device is affected, Mylan has provided a chart detailing the recalled lots along with their expiration dates.
This isn’t the first time Mylan has been in the spotlight regarding their EpiPen. Last summer, the company faced public backlash for dramatically increasing the price of the device. After widespread outcry, the price was reduced from a staggering $600 to $300, even though it costs only about $30 to produce. Despite the high cost, the company’s commitment to user safety is commendable. If you have an EpiPen or EpiPen Jr., especially one kept at school for your child, it’s wise to check if it falls under this recall. For those affected, Mylan has instructions available on their site for obtaining a replacement. Consumers are advised to retain their current pens until a new one is provided.
For further information on the journey of home insemination, you can explore our article on Couples’ Fertility Journey. Additionally, if you’re looking for a reliable insemination tool, check out the Cryobaby Home Intracervical Insemination Syringe Kit Combo. And for comprehensive information related to pregnancy, the CDC is an excellent resource found here.
In summary, Mylan is taking responsible steps to recall specific lots of EpiPen devices due to a potential defect that could hinder their functionality. Consumers should verify their devices against the recalled lots and follow Mylan’s guidelines for replacements.
Keyphrase: EpiPen recall
Tags: [“home insemination kit”, “home insemination syringe”, “self insemination”]